Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy
Abstract This randomized clinical trial evaluates the use of transdermal cannabidiol vs placebo for adults with drug-resistant focal epilepsy. Authors: Terence J. O’Brien, Samuel F. Berkovic, Jacqueline A. French, John A. Messenheimer, Terri B. Sebree, Marcel O. Bonn-Miller, Donna L. Gutterman Affiliations: Department of Neuroscience, The Central Clinical School, Monash University and The Alfred Centre, Melbourne, Victoria, Australia; Department of Neurology, The Central Clinical School, Monash University and The Alfred Centre, Melbourne, Victoria, Australia; Department of Medicine, The University of
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in